Approval of malaria vaccine could provide a shot in the arm.

Baxter Is Worth a Look Real Money Pro($)

We are not ready to pull the buy trigger yet.
The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.

Merger Mania Benefits Mylan Real Money Pro($)

Whether it's acquiring or the acquired, Mylan is building shareholder value.
Is the company's stock about to start losing weight?

Buy Gilead Sciences Real Money Pro($)

Its prospects exploded with a breakthrough drug.
For speculative investors.
The CEO of Allergan has created value for shareholders.

Shotgun Investing in Biotech Real Money Pro($)

Two speculative plays are worthy of consideration.

The Fibocall: Celgene Real Money Pro($)

This beloved stock has triggered a long-term overbought signal again.

Columnist Conversations

Market has cut losses from lows in response triggered by poor auto sales, manufacturing & ADP reports. Wi...
FIBOCALL: Amgen (AMGN) last generated a long-term overbought condition on the Dec. 9 close of $169.39 The shar...
Today we are 24 days down which is equal to a prior decline in time and we are also testing the lower support....
This market is NOT in a downtrend, but it IS failing so far against key monthly resistance as discussed in Off...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.